Frequency Therapeutics Inc
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About KRRO
Korro Bio, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops, and commercializes genetic medicines based on editing ribonucleic acid (RNA), enabling treatment of both rare and highly prevalent diseases. The Company is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, it is expanding the reach of genetic medicines. Using its oligonucleotide-based approach, the Company brings its medicines to patients by leveraging its proprietary platform. The Company’s first development candidate, KRRO-110, is in development as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD) that has the potential to be disease-modifying and provide a differentiated therapeutic option.
Find out what a historical investment in Frequency Therapeutics Inc would be worth today using our KRRO stock calculator.
$77.50M
-
0.00%
384.41K
$8.83
$7.79
$7.86
$55.89
$5.20
Ready to start your investing journey with Stake?
Open an accountKRRO FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in KRRO
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in KRRO
on Stake
Buy KRRO from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of KRRO from only US$10 with fractional shares
